by Richard Daverman, PhD
April 21, 2014 -- Chindex, which operates private hospitals and clinics in China, accepted a buy-out offer of $24 per share from company insiders, which values the company at $434 million. The latest offer tops a $23 per share bid by an unnamed suitor, which refused the board’s invitation to raise its offer. The insiders consist of Fosun Pharma, which already owns 17.5% of Chindex, the US private equity group TPG and Roberta Lipson, the company’s founder and CEO. More details....
Stock Symbols: (NSDQ: CHDX) (SHA: 000196; HK: 2196)
Help employers find you! Check out all the jobs and post your resume.
